Go Pro

Mobia Medical (MOBI) Competitors

Mobia Medical logo
$10.18 +0.17 (+1.70%)
As of 01:54 PM Eastern

MOBI vs. KMTS, CNMD, ATEC, TNDM, and DRTS

Should you buy Mobia Medical stock or one of its competitors? Mobia Medical's main competitors and comparable companies include Kestra Medical Technologies (KMTS), CONMED (CNMD), Alphatec (ATEC), Tandem Diabetes Care (TNDM), and Alpha Tau Medical (DRTS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Mobia Medical compare to Kestra Medical Technologies?

Kestra Medical Technologies (NASDAQ:KMTS) and Mobia Medical (NASDAQ:MOBI) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

In the previous week, Kestra Medical Technologies had 13 more articles in the media than Mobia Medical. MarketBeat recorded 15 mentions for Kestra Medical Technologies and 2 mentions for Mobia Medical. Mobia Medical's average media sentiment score of 1.45 beat Kestra Medical Technologies' score of 0.28 indicating that Mobia Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kestra Medical Technologies
6 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Mobia Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Mobia Medical has a net margin of 0.00% compared to Kestra Medical Technologies' net margin of -138.35%. Mobia Medical's return on equity of 0.00% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Kestra Medical Technologies-138.35% -57.38% -41.10%
Mobia Medical N/A N/A N/A

Kestra Medical Technologies currently has a consensus target price of $28.14, indicating a potential upside of 18.69%. Mobia Medical has a consensus target price of $20.75, indicating a potential upside of 103.83%. Given Mobia Medical's stronger consensus rating and higher possible upside, analysts clearly believe Mobia Medical is more favorable than Kestra Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kestra Medical Technologies
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43
Mobia Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57

Mobia Medical has lower revenue, but higher earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kestra Medical Technologies$95.13M14.61-$131.61M-$2.42N/A
Mobia Medical$32.04M10.58-$46.50M-$20.18N/A

Summary

Mobia Medical beats Kestra Medical Technologies on 9 of the 13 factors compared between the two stocks.

How does Mobia Medical compare to CONMED?

CONMED (NYSE:CNMD) and Mobia Medical (NASDAQ:MOBI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings.

CONMED has a net margin of 4.12% compared to Mobia Medical's net margin of 0.00%. CONMED's return on equity of 14.31% beat Mobia Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
CONMED4.12% 14.31% 6.33%
Mobia Medical N/A N/A N/A

CONMED has higher revenue and earnings than Mobia Medical. Mobia Medical is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CONMED$1.37B1.01$47.06M$1.8525.10
Mobia Medical$32.04M10.58-$46.50M-$20.18N/A

CONMED currently has a consensus price target of $41.40, indicating a potential downside of 10.84%. Mobia Medical has a consensus price target of $20.75, indicating a potential upside of 103.83%. Given Mobia Medical's stronger consensus rating and higher probable upside, analysts plainly believe Mobia Medical is more favorable than CONMED.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CONMED
2 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.75
Mobia Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57

In the previous week, Mobia Medical had 1 more articles in the media than CONMED. MarketBeat recorded 2 mentions for Mobia Medical and 1 mentions for CONMED. Mobia Medical's average media sentiment score of 1.45 beat CONMED's score of 0.00 indicating that Mobia Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CONMED
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Mobia Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

CONMED beats Mobia Medical on 7 of the 13 factors compared between the two stocks.

How does Mobia Medical compare to Alphatec?

Mobia Medical (NASDAQ:MOBI) and Alphatec (NASDAQ:ATEC) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, analyst recommendations and risk.

Mobia Medical presently has a consensus target price of $20.75, suggesting a potential upside of 103.83%. Alphatec has a consensus target price of $17.40, suggesting a potential upside of 61.50%. Given Mobia Medical's higher probable upside, research analysts clearly believe Mobia Medical is more favorable than Alphatec.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mobia Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
Alphatec
1 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.80

In the previous week, Alphatec had 7 more articles in the media than Mobia Medical. MarketBeat recorded 9 mentions for Alphatec and 2 mentions for Mobia Medical. Mobia Medical's average media sentiment score of 1.45 beat Alphatec's score of 1.15 indicating that Mobia Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mobia Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alphatec
4 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Mobia Medical has higher earnings, but lower revenue than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mobia Medical$32.04M10.58-$46.50M-$20.18N/A
Alphatec$764.16M2.18-$143.36M-$0.71N/A

66.4% of Alphatec shares are held by institutional investors. 13.5% of Alphatec shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Mobia Medical has a net margin of 0.00% compared to Alphatec's net margin of -13.49%. Mobia Medical's return on equity of 0.00% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Mobia MedicalN/A N/A N/A
Alphatec -13.49%-6,752.24%-13.88%

Summary

Mobia Medical beats Alphatec on 8 of the 15 factors compared between the two stocks.

How does Mobia Medical compare to Tandem Diabetes Care?

Tandem Diabetes Care (NASDAQ:TNDM) and Mobia Medical (NASDAQ:MOBI) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends, media sentiment and valuation.

In the previous week, Tandem Diabetes Care had 4 more articles in the media than Mobia Medical. MarketBeat recorded 6 mentions for Tandem Diabetes Care and 2 mentions for Mobia Medical. Tandem Diabetes Care's average media sentiment score of 1.56 beat Mobia Medical's score of 1.45 indicating that Tandem Diabetes Care is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tandem Diabetes Care
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Mobia Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Mobia Medical has lower revenue, but higher earnings than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tandem Diabetes Care$1.01B1.17-$204.71M-$0.93N/A
Mobia Medical$32.04M10.58-$46.50M-$20.18N/A

Tandem Diabetes Care currently has a consensus target price of $29.34, indicating a potential upside of 71.50%. Mobia Medical has a consensus target price of $20.75, indicating a potential upside of 103.83%. Given Mobia Medical's stronger consensus rating and higher probable upside, analysts clearly believe Mobia Medical is more favorable than Tandem Diabetes Care.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tandem Diabetes Care
1 Sell rating(s)
11 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.48
Mobia Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57

Mobia Medical has a net margin of 0.00% compared to Tandem Diabetes Care's net margin of -6.08%. Mobia Medical's return on equity of 0.00% beat Tandem Diabetes Care's return on equity.

Company Net Margins Return on Equity Return on Assets
Tandem Diabetes Care-6.08% -45.97% -6.23%
Mobia Medical N/A N/A N/A

Summary

Mobia Medical beats Tandem Diabetes Care on 8 of the 14 factors compared between the two stocks.

How does Mobia Medical compare to Alpha Tau Medical?

Mobia Medical (NASDAQ:MOBI) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

Alpha Tau Medical has lower revenue, but higher earnings than Mobia Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mobia Medical$32.04M10.58-$46.50M-$20.18N/A
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A

Mobia Medical's return on equity of 0.00% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Mobia MedicalN/A N/A N/A
Alpha Tau Medical N/A -138.12%-81.68%

Mobia Medical currently has a consensus price target of $20.75, suggesting a potential upside of 103.83%. Alpha Tau Medical has a consensus price target of $15.40, suggesting a potential upside of 6.10%. Given Mobia Medical's stronger consensus rating and higher probable upside, equities research analysts plainly believe Mobia Medical is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mobia Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.38

In the previous week, Mobia Medical and Mobia Medical both had 2 articles in the media. Alpha Tau Medical's average media sentiment score of 1.61 beat Mobia Medical's score of 1.45 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mobia Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

2.7% of Alpha Tau Medical shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Mobia Medical beats Alpha Tau Medical on 6 of the 11 factors compared between the two stocks.

Get Mobia Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MOBI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MOBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MOBI vs. The Competition

MetricMobia MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$338.89M$5.44B$7.21B$13.06B
Dividend YieldN/A1.80%2.57%11.71%
P/E Ratio-0.5025.13274.4325.51
Price / Sales10.5844.48636.2488.64
Price / CashN/A33.0328.4234.96
Price / BookN/A6.0210.456.26
Net Income-$46.50M$150.14M$3.49B$358.19M
7 Day Performance-12.47%-2.36%-2.08%-1.27%
1 Month Performance-13.44%-2.88%0.62%-2.53%
1 Year PerformanceN/A9.76%24.75%8.81%

Mobia Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MOBI
Mobia Medical
4.2518 of 5 stars
$10.18
+1.7%
$20.75
+103.8%
N/A$338.89M$32.04MN/A167
KMTS
Kestra Medical Technologies
2.0234 of 5 stars
$25.54
+1.6%
$28.14
+10.2%
+4.7%$1.50B$95.13MN/A300
CNMD
CONMED
1.153 of 5 stars
$48.97
-0.9%
$41.40
-15.5%
-12.8%$1.48B$1.37B26.473,900
ATEC
Alphatec
4.2118 of 5 stars
$9.45
+1.3%
$17.40
+84.1%
-30.7%$1.46B$815.05MN/A700
TNDM
Tandem Diabetes Care
2.8742 of 5 stars
$19.90
-2.6%
$28.98
+45.6%
+39.4%$1.38B$1.04BN/A2,500

Related Companies and Tools


This page (NASDAQ:MOBI) was last updated on 9/14/2026 by MarketBeat.com Staff.
From Our Partners